Charlotte Wilhelm Benartzi

2PUBLICATIONS
3CO-AUTHORS
Cancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 16, 2024
Safety and efficacy of itacitinib, a selective JAK1 inhibitor, in advanced hepatocellular cancer: Phase 1b trial (JAKAL).

Alessandro Troiani, Maria Martinez, Caroline Ward

|Dec 08, 2021
Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes.

Charlotte S Wilhelm-Benartzi, Sarah E Miller, Sylvaine Bruggraber

Pageof 1

Frequent Collaborators

1 joint publications

David Dunger

1 joint publications

Alessandro Troiani

1 joint publications

David J Pinato